Scientists in Japan have discovered that a natural compound found in a type of ginger called kencur can throw cancer cells ...

Rova-T’s limited efficacy in glioblastoma—attributed to suboptimal tumor penetration and compensatory signaling—exemplifies these challenges (122, 123). Figure 2. Future Directions in DLL3-Targeted ...

BackgroundRecent evidence suggests that inflammation is relevant to carcinogenesis and tumor progression ... neutrophil-to-lymphocyte ratio (NLR), Pulmonary carcinoid, Survival & prognosis, non-small ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received previous treatment, the drugmaker said on Wednesday.

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.

May 13 (Reuters) - Britain's GSK (GSK.L), opens new tab and drug developer iTeos Therapeutics (ITOS.O), opens new tab said on Tuesday they have stopped developing an experimental lung cancer drug ...